Literature DB >> 8344192

Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion.

B H Fasciotto1, C A Trauss, G H Greeley, D V Cohn.   

Abstract

Chromogranin A (CgA), previously referred to as secretory protein-I, is a 50-kilodalton protein present in secretory granules of many endocrine and neuroendocrine cells. In the parathyroid it is present and cosecreted with PTH in response to hypocalcemia. CgA appears to be a precursor of bioactive peptides including pancreastatin, beta-granin, vasostatin, and chromostatin. The presence of several highly conserved pairs of basic amino acids, putative cleavage sites, in the CgA molecule suggests that other yet unidentified bioactive peptides might exist within the molecule. We tested this speculation by subjecting porcine parathyroid CgA to digestion by endoproteinase Lys-C. Resulting CgA-derived peptides were isolated by reverse-phase C18 HPLC and tested for their ability to affect low-Ca2+ stimulated secretion by porcine parathyroid cells. We characterized one peptide, which we named parastatin, that inhibited secretion of both PTH and CgA in a dose-dependent fashion over the range of 0.2-0.6 microM. Parastatin migrated as a single band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis with an apparent mol wt of 11,000. Edman degradation yielded the sequence L-S-F-R-A-P-A-Y-G-F-R-G-P-G-L corresponding to residues 347-361 of porcine CgA. Amino acid analysis of endoproteinase Lys-C and endoproteinase Asp-N-generated fragments indicated that parastatin corresponds to residues 347-419 of CgA. A synthetic NH2-terminal fragment of rat parastatin corresponding to residues 1-19 was an inhibitory as intact porcine parastatin on parathyroid gland secretion. These results extend the concept that CgA is a precursor of biologically active peptides.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8344192     DOI: 10.1210/endo.133.2.8344192

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

1.  The chromogranins and the counter-regulatory hormones: do they make homeostatic sense?

Authors:  J H Koeslag; P T Saunders; J A Wessels
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

2.  Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway.

Authors:  N L Eskeland; A Zhou; T Q Dinh; H Wu; R J Parmer; R E Mains; D T O'Connor
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Chromogranin A transcription and gene expression in Folliculostellate (TtT/GF) cells inhibit cell growth.

Authors:  Gail A Stilling; Jill M Bayliss; Long Jin; Heyu Zhang; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

4.  Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).

Authors:  L Taupenot; S K Mahata; H Wu; D T O'Connor
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

5.  A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders.

Authors:  Lakshmi Subramanian; Abrar A Khan; Prasanna K R Allu; Malapaka Kiranmayi; Bhavani S Sahu; Saurabh Sharma; Madhu Khullar; Ajit S Mullasari; Nitish R Mahapatra
Journal:  J Biol Chem       Date:  2017-06-30       Impact factor: 5.157

6.  Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.

Authors:  S K Mahata; D T O'Connor; M Mahata; S H Yoo; L Taupenot; H Wu; B M Gill; R J Parmer
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

7.  Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide Pathway.

Authors:  Malapaka Kiranmayi; Venkat R Chirasani; Prasanna K R Allu; Lakshmi Subramanian; Elizabeth E Martelli; Bhavani S Sahu; Durairajpandian Vishnuprabu; Rathnakumar Kumaragurubaran; Saurabh Sharma; Dhanasekaran Bodhini; Madhulika Dixit; Arasambattu K Munirajan; Madhu Khullar; Venkatesan Radha; Viswanathan Mohan; Ajit S Mullasari; Sathyamangla V Naga Prasad; Sanjib Senapati; Nitish R Mahapatra
Journal:  Hypertension       Date:  2016-06-20       Impact factor: 10.190

Review 8.  The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.

Authors:  P Rosa; H H Gerdes
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

9.  Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues.

Authors:  R Kirchmair; B Leitner; R Fischer-Colbrie; J Marksteiner; R Hogue-Angeletti; H Winkler
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

10.  Inhibition of proopiomelanocortin expression by an oligodeoxynucleotide complementary to beta-endorphin mRNA.

Authors:  S Spampinato; M Canossa; L Carboni; G Campana; G Leanza; S Ferri
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.